Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Palestine flag Palestine · Delayed Price · Currency is JOD · Price in USD
4.750
+0.050 (1.06%)
At close: Dec 4, 2025
32.68%
Market Cap 60.58M
Revenue (ttm) 33.42M
Net Income (ttm) 6.98M
Shares Out 18.00M
EPS (ttm) 0.39
PE Ratio 8.69
Forward PE n/a
Dividend 0.06 (1.68%)
Ex-Dividend Date Apr 30, 2025
Volume 690
Average Volume 2,742
Open 4.700
Previous Close 4.700
Day's Range 4.700 - 4.750
52-Week Range 3.550 - 4.750
Beta -0.01
RSI 73.83
Earnings Date Nov 11, 2025

About Jerusalem Pharmaceuticals

Jerusalem Pharmaceuticals Co. Ltd. develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally. It offers range of over-the-counter, prescription pharmaceutical, and nutritional supplements products. The company produces approximately 300 pharmaceutical products in various dosage forms, such as tablets, capsules, sterile injectables, suspensions, syrups, powders, suppositories, ovules, creams, ointments, and ear and nose drops, as well as solutions. It also produces detergent, cos... [Read more]

Industry Pharmaceutical Preparations
Founded 1969
Employees 531
Stock Exchange Palestine Stock Exchange
Ticker Symbol JPH
Full Company Profile

Financial Performance

In 2024, Jerusalem Pharmaceuticals's revenue was $39.82 million, an increase of 0.42% compared to the previous year's $39.65 million. Earnings were $5.04 million, a decrease of -27.58%.

Financial numbers in USD Financial Statements

News

There is no news available yet.